Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Williams Mark D. | 0001769059 | Jul-28-2020 | director, 10 percent owner, officer: President, CEO & CFO |
Gibson Colin | 0001768925 | Jun-17-2019 | director, 10 percent owner, officer: Vice President |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Mycotopia Therapies, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
PRE 14C | Document | Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001096906-24-000121 (34 Act) Size: 95 KB |
Jan-29-2024 | 24574362 |
8-K | Document | Current report filing Acc-no: 0001096906-23-002316 (34 Act) Size: 674 KB |
Dec-05-2023 | 231464582 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-002130 (34 Act) Size: 2408 KB |
Nov-13-2023 | 231394925 |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001096906-23-002096 (34 Act) Size: 3172 KB |
Nov-06-2023 | 231379125 |
10-Q/A | Document | Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-002094 (34 Act) Size: 2926 KB |
Nov-06-2023 | 231379077 |
10-Q/A | Document | Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-002008 (34 Act) Size: 2899 KB |
Oct-17-2023 | 231330298 |
10-Q/A | Document | Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-002006 (34 Act) Size: 2473 KB |
Oct-17-2023 | 231330231 |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001096906-23-002003 (34 Act) Size: 2868 KB |
Oct-17-2023 | 231329998 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-001623 (34 Act) Size: 2713 KB |
Aug-17-2023 | 231181165 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001096906-23-001605 (34 Act) Size: 25 KB |
Aug-14-2023 | 231172124 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-23-001409 (34 Act) Size: 2288 KB |
Jul-14-2023 | 231088618 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001096906-23-001075 (34 Act) Size: 25 KB |
May-15-2023 | 23920631 |
8-K | Document | Current report filing Acc-no: 0001096906-23-000961 (34 Act) Size: 148 KB |
May-03-2023 | 23882218 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001096906-23-000683 (34 Act) Size: 3033 KB |
Mar-30-2023 | 23779868 |
8-K | Document | Current report filing Acc-no: 0001096906-23-000428 (34 Act) Size: 200 KB |
Feb-22-2023 | 23650963 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-22-002761 (34 Act) Size: 2402 KB |
Nov-14-2022 | 221385893 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-22-001838 (34 Act) Size: 2334 KB |
Aug-11-2022 | 221155406 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001096906-22-001262 (34 Act) Size: 2087 KB |
May-23-2022 | 22951658 |
8-K | Document | Current report filing Acc-no: 0001096906-22-001188 (34 Act) Size: 891 KB |
May-19-2022 | 22942161 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001096906-22-001166 (34 Act) Size: 23 KB |
May-17-2022 | 22932870 |
Recent 20 filings. View all Mycotopia Therapies, Inc. filings
Thanks I look forward to using the product to improve my skin tone
It's being easier working on the website. And I recommend, it's a great website
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by